These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8999661)

  • 1. [Effect of docanol on the status of hemostasis and fibrinolysis systems, as well as lipid spectrum in patients with ischemic heart disease depending on the initial level of fibrinolytic activity].
    Liutova LV; Karabasova MA; Andreenko GV; Panchenko VM; Isaev VA; Sorokaletov SM; ERshov AA
    Vopr Med Khim; 1996; 42(1):64-70. PubMed ID: 8999661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence polyunsaturated fatty acids omega-3 on coagulation and fibrinolysis systems in patients with NIDDM].
    Panchenko VM; Karabasova MA; Liutova LV; Togoev AM; Ershov AA; Chernova GI; Isaev VA
    Klin Med (Mosk); 2002; 80(2):40-3. PubMed ID: 11898721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of piyavit on hemostatic processes and fibrinolysis in patients with ischemic heart disease].
    Panchenko VM; Serebriakova TN; Podorol'skaia LV; Sorokoletov SM; Dzhanashiia PKh
    Eksp Klin Farmakol; 1995; 58(3):28-31. PubMed ID: 7663290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The status of coagulation and lipid blood spectrum in patients with peptic ulcer complicated by ischemic heart disease].
    Zvenigorodskaia LA; Nilova TV
    Ross Gastroenterol Zh; 2001; (2):37-41. PubMed ID: 11681183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of tycveinol on the lipid transport system and hemostasis and fibrinolysis systems in patients with ischemic heart disease].
    Panchenko VM; Liutova LV; Karabasova MA; Ershov AA; Isaev VA
    Klin Med (Mosk); 2002; 80(9):54-6. PubMed ID: 12416228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of eifitol on lipid metabolism in patients with clinically different ischemic heart diseases].
    Panchenko VM; Nazlukhanian SO; Isaev VA; Ershov AA; Chernova GI; Liutova LV; Andreenko GV; Dzhanashiia PK
    Klin Med (Mosk); 1997; 75(3):39-41. PubMed ID: 9229613
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
    Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
    Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
    Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV
    Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
    Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of long-term Enduracin monotherapy on the clinical and biochemical status of patients with ischemic heart disease].
    Kukharchuk VV; Solov'ev EIu; Malyshev PP; Rozhkova TA; Semenova OA; Aronskaia EE
    Ter Arkh; 1997; 69(9):41-5. PubMed ID: 9411824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term administration of tyquanol in the treatment of patients with ischemic heart disease in combination with hyperlipidemia].
    Panchenko VM; Ershov AA; Isaev VA
    Klin Med (Mosk); 2003; 81(3):40-2. PubMed ID: 12698850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia.
    Castro IA; Monteiro VC; Barroso LP; Bertolami MC
    Nutrition; 2007 Feb; 23(2):127-37. PubMed ID: 17234506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clinofibrate on plasma fibrinogen level in high fructose diet-induced hyperlipidemic rats.
    Okazaki M; Zhang H; Ichino K; Amamiya M; Nakayama S; Oguchi K
    In Vivo; 1994; 8(6):1057-61. PubMed ID: 7772737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
    Kalweit G; Bach J; Huwer H; Winning J; Hellstern P
    Thromb Res; 2005; 116(1):33-9. PubMed ID: 15850606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative efficiency of prolonged diet and drug therapies for hyperlipidemias in patients with ischemic heart disease].
    Mal' GS
    Klin Med (Mosk); 2004; 82(5):63-6. PubMed ID: 15230046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.